Story perspectives

CAR T Therapy Shows Promise for Autoimmune Disorders

4/14/2026

Summary

Story summary

In April 2026, a Med study reports that CAR T therapy was used under compassionate use for a patient with autoimmune hemolytic anemia, immune thrombocytopenia, and antiphospholipid antibody syndrome, who has been symptom-free for over a year.
The case demonstrates potential for CAR T therapy beyond cancer, showing a modified T-cell approach addressing multiple autoimmune conditions.
The patient had relied on ineffective steroids before receiving CAR T therapy.

1 of 1

Story summary

In April 2026, a Med study reports that CAR T therapy was used under compassionate use for a patient with autoimmune hemolytic anemia, immune thrombocytopenia, and antiphospholipid antibody syndrome, who has been symptom-free for over a year.
The case demonstrates potential for CAR T therapy beyond cancer, showing a modified T-cell approach addressing multiple autoimmune conditions.
The patient had relied on ineffective steroids before receiving CAR T therapy.